TRUE Private Wealth Advisors’s INmune Bio INMB Stock Holding History

TRUE Private Wealth Advisors’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,000	Closed	-$10K	–	745
2020 Q3	$10K	Hold	1,000	–	–	﹤0.01%	497
2020 Q2	$5K	Hold	1,000	–	–	﹤0.01%	560
2020 Q1	$3K	Hold	1,000	–	–	﹤0.01%	575
2019 Q4	$5K	Buy	+1,000	New	+$4.82K	﹤0.01%	675
2019 Q3	–	Sell	-1,000	Closed	-$9K	–	470
2019 Q2	$9K	Buy	+1,000	New	+$10.1K	﹤0.01%	562

Other funds holding INMB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAIM

Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

TRUE Private Wealth Advisors's INMB Position: Q4 2020 in Review

TRUE Private Wealth Advisors sold out of INmune Bio (INMB) in Q4 2020, closing a stake of 1,000 shares — an estimated $10K sold.

TRUE Private Wealth Advisors first reported a position in INMB in Q2 2019 and held it in 5 quarters. The position peaked at $10K in Q3 2020. 26 funds tracked by Wall St. Rank hold INMB as of Q4 2020.

TRUE Private Wealth Advisors reported no remaining INmune Bio position as of Q4 2020 after selling out during the quarter.
TRUE Private Wealth Advisors sold 1,000 INmune Bio shares in Q4 2020, an estimated $10K.
TRUE Private Wealth Advisors first reported a position in INmune Bio in Q2 2019 and held it in 5 quarters.
TRUE Private Wealth Advisors's INmune Bio position peaked at $10K in Q3 2020.
26 funds tracked by Wall St. Rank held INmune Bio as of Q4 2020.

Based on TRUE Private Wealth Advisors's 13F filing for Q4 2020, filed 11 Jan 2021.